First Tracks Biotherapeutics, Inc. (TRAX)

TRAX Statistics

Total Valuation

TRAX has a market cap or net worth of $678.99 million. The enterprise value is $381.47 million.

Market Cap	678.99M
Enterprise Value	381.47M

Important Dates

The next estimated earnings date is Monday, June 1, 2026.

Earnings Date	Jun 1, 2026
Ex-Dividend Date	n/a

Share Statistics

TRAX has 34.75 million shares outstanding.

Current Share Class	34.75M
Shares Outstanding	34.75M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.83%
Owned by Institutions (%)	4.38%
Float	30.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.36
P/TBV Ratio	2.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.20, with a Debt / Equity ratio of 0.05.

Current Ratio	10.20
Quick Ratio	10.05
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.91% and return on invested capital (ROIC) is -31.55%.

Return on Equity (ROE)	-48.91%
Return on Assets (ROA)	-28.97%
Return on Invested Capital (ROIC)	-31.55%
Return on Capital Employed (ROCE)	-59.76%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.60M
Employee Count	104
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.28
Average Volume (20 Days)	464,469

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-139.61M
Operating Income	-179.01M
Pretax Income	-166.09M
Net Income	-166.09M
EBITDA	-178.45M
EBIT	-179.01M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $311.64 million in cash and $14.11 million in debt, with a net cash position of $297.53 million or $8.56 per share.

Cash & Cash Equivalents	311.64M
Total Debt	14.11M
Net Cash	297.53M
Net Cash Per Share	$8.56
Equity (Book Value)	287.49M
Book Value Per Share	n/a
Working Capital	285.38M

Cash Flow

In the last 12 months, operating cash flow was -$142.93 million and capital expenditures -$87,000, giving a free cash flow of -$143.01 million.

Operating Cash Flow	-142.93M
Capital Expenditures	-87,000
Depreciation & Amortization	559,000
Net Borrowing	n/a
Free Cash Flow	-143.01M
FCF Per Share	-$4.12

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-24.46%
FCF Yield	-21.06%

Analyst Forecast

The average price target for TRAX is $41.00, which is 109.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.00
Price Target Difference	109.83%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1